Abaxis settles Cepheid lawsuit for $17.25 million

Associated Press Modified: September 26, 2012 at 12:00 pm •  Published: September 26, 2012
Advertisement
;

UNION CITY, Calif. (AP) — Blood analysis systems developer Abaxis Inc. said Wednesday it will receive $17.25 million from medical test maker Cepheid Inc. as part of a patent litigation settlement.

Abaxis, based in Union City, Calif., said the litigation focused on several of its patents tied to reagent and chemical compositions and processes. All claims against Cepheid will be dismissed as part of the settlement.

The agreement allows both companies to move forward "without the distraction of protracted litigation," Abaxis CEO Clint Severson said in a brief statement.

Cepheid, which is based in Sunnyvale, Calif., said in a Securities and Exchange filing issued Tuesday that the settlement was a compromise and not a concession or admission of liability by either side.

Abaxis shares slipped 9 cents to $36.24 in afternoon trading Wednesday, while Cepheid shares rose 45 cents to $39.40 and broader trading indexes fell slightly.



Trending Now


AROUND THE WEB

  1. 1
    Brazilians Listened to the Song ‘Happy’ a Lot More After Their World Cup Disaster Against...
  2. 2
    Dorman blasts "Fal-esi" education program
  3. 3
    These Two Desks Could Help You Live Longer
  4. 4
    Meet the World's Fastest Talking Woman
  5. 5
    OU football: Trevor Knight among elite quarterbacks at Manning Passing Academy
+ show more